Literature DB >> 7431975

Surgical correction of recurrent sustained ventricular tachycardia following complete repair of tetralogy of Fallot.

A H Harken, L N Horowitz, M E Josephson.   

Abstract

Ventricular arrhythmias occur in 0.3% to 3% of patients following complete repair of tetralogy of Fallot. These life-threatening arrhythmias do not appear related to the hemodynamic success of the repair. This report presents the case histories of two patients who experienced from 30 to 150 documented episodes of sustained ventricular tachycardia (VT) following complete repair of tetralogy of Fallot. Pharmacologic and pacing regimens failed to prevent recurrence in both patients. The source of the arrhythmia was localized to the right ventriculotomy scar by electrophysiological mapping. This scar was surgically excised. VT was not inducible following operation and has not recurred in the 6 months and 18 months following discharge of the patients from the hospital. If medical therapy fails, operation combined with extensive preoperative and intraoperative electrophysiological study may be a realistic option in the treatment of selected patients with VT following complete repair of tetralogy of Fallot.

Entities:  

Mesh:

Year:  1980        PMID: 7431975

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Mark E Josephson: Clinical Investigator.

Authors:  John M Miller
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-04

2.  Management of ventricular arrhythmias in adults with congenital heart disease.

Authors:  Steven Fishberger
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

3.  Later potentials on signal-averaged electrocardiograms in children after right ventriculotomy.

Authors:  L Rovamo; M Mäkijärvi; E Pesonen; E I Wallgren; L Toivonen
Journal:  Pediatr Cardiol       Date:  1995 May-Jun       Impact factor: 1.655

Review 4.  Results of direct surgical ablation of ventricular tachycardia not due to ischemic heart disease.

Authors:  G M Lawrie; A Pacifico; R Kaushik
Journal:  Ann Surg       Date:  1989-06       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.